• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Advisory Committees

  • Print
  • Share
  • E-mail

September 20, 2011: Vaccines and Related Biological Products Advisory Committee Meeting Agenda

AGENDA
Food and Drug Administration
Center for Biologics Evaluation and Research
Vaccines and Related Biological Products Advisory Committee
127th Meeting via Teleconference
National Institutes of Health
Bldg. 29B, Conference Room C
September 20, 2011

Open Session

1:00 p.m.Call to Order and Opening RemarksJose Romero, M.D., Chair
 Conflict of Interest StatementDonald Jehn, M.S., FDA

Topic I

Presentation of Laboratory of Enteric and Sexually Transmitted Diseases, Division of Bacterial, Parasitic, and Allergenic Products, Office of Vaccines Research and Review, Center for Biologics Evaluation and Research

1:15Overview of Research/Site Visit Process, Center Biologics Evaluation and Research (CBER)Carolyn Wilson, Ph.D., FDA
1:30Overview Office of Vaccines Research and Review (OVRR), CBERKonstantin Chumakov, Ph.D., FDA
1:45Overview Division of Bacterial, Parasitic, And Allergenic Products, OVRRJay Slater, M.D., FDA
2:00Overview Laboratory of Laboratory of Enteric And Sexually Transmitted DiseasesScott Stibitz, Ph.D., FDA
2:30Open Public Hearing (if no speakers, will move directly to closed session) 
3:30Closed Session 
4:00

Adjourn Meeting